Understanding the effects of banning menthol cigarettes on public health.
Modeling the public health impact of a national menthol cigarette ban.
This study looks at how a nationwide ban on menthol cigarettes could help improve health by reducing smoking, especially among young people, and it aims to see how this change might lower the risk of heart disease and cancer.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10673903 on NIH RePORTER |
What this research studies
This research investigates the potential public health impact of a national ban on menthol cigarettes, which are known to be particularly appealing to young smokers and harder to quit. By using advanced microsimulation modeling techniques, the study aims to estimate how such a ban could affect tobacco use patterns and related health outcomes, specifically focusing on cardiovascular diseases and cancers. The research will analyze data from national surveys to track changes in smoking behavior over time and inform regulatory decisions by the FDA.
Who could benefit from this research
Good fit: Ideal candidates for this research are current smokers, particularly those who use menthol cigarettes, including youth and individuals from low-income or racial/ethnic minority backgrounds.
Not a fit: Patients who do not smoke or have never used menthol cigarettes may not benefit directly from this research.
Why it matters
Potential benefit: If successful, this research could lead to significant reductions in smoking rates and tobacco-related diseases among vulnerable populations.
How similar studies have performed: Previous research has indicated that tobacco control measures, including bans on flavored cigarettes, can lead to improved public health outcomes, suggesting that this approach may be effective.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Mills, Sarah — Univ of North Carolina Chapel Hill
- Study coordinator: Mills, Sarah
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.